Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Joe Kiani Exits Amid Legal Clash Masimo stock is up as the company announces leadership changes, reiterates strong financial guidance, and expects Q3 revenue of $495M-$515M. Nabaparna Bhattacharya ...

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 38%. Looking ahead, revenue ...

Wells Fargo analyst Vik Chopra has assigned their bullish stance on MASI stock, giving a Buy rating yesterday. Vik Chopra has given his Buy ...

Piper Sandler raised the firm’s price target on Masimo (MASI) to $180 from $165 and keeps an Overweight rating on the shares. The firm ...

Today we will run through one way of estimating the intrinsic value of Masimo Corporation ( NASDAQ:MASI) by taking the expected future cash flows and discounting them to today's value. One way to ...

The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast ... Irvine, CA-based Masimo Corporation develops ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

Masimo Corp. is suing founder Joe Kiani—who lost a takeover fight last month against Politan Capital Management LP—saying he ...